
|
|
![]() | ![]() | ![]() | ![]() |


ProShares Ultra Health Care (RXL) |


Suggest other news sources for this topic

WIKI ANALYSIS| This article describes an exchange traded fund that tracks an index, commodity, currency, or varied basket of securites. View articles referencing this fund. |
The Proshares Ultra Health Care (RXL)
Profile: Proshares Ultra Health Care (RXL) is an Exchange Traded Fund (ETF) that seeks to mimic the daily investment results, before fees and expenses, corresponding to twice the daily performance of the Dow Jones US Health Care Index. In other words, if this underlying index declines by 1% for the day, the NAV of RXL will more or less decline by 2%, before fees and expenses. In the same manner, if this underlying index rises by 1% for the day, the NAV of RXL rises by 2% as well.
Inception Date: 01/30/07
Fund Information
Investment Strategy: The principal investment strategies of this fund include:
Annual Fund Operating Expenses | Investment Advisory Fee: | 0.75% |
| Distribution and Service (12b-1) Fee: | 0.00% |
| Other Expenses: | 1.00% |
| Total Annual Fund Operating Expenses: | 1.75% |
| Fee Waivers / Reimbursements: | -0.80% |
| Total Net Annual Fund Operating Expenses: | 0.95% |
Top 10 Holdings: (As of February 13, 2009) | Company | Weight |
|---|---|
| Johnson and Johnson | 12.27% |
| Pfizer | 7.56% |
| Abbott Laboratories | 6.50% |
| Amgen Inc. | 4.71% |
| Merck & Co. Inc. | 4.67% |
| Wyeth | 4.45% |
| Gilead Sciences | 3.52% |
| Bristol Myers Squibb Co. | 3.29% |
| Genentech | 2.97% |
| Medtronic | 2.83% |
Other Healthcare ETFs
Reference: Company Website: http://www.proshares.com



| |||||||